To access information about Pandox's initial public offering, please follow the instructions below.

Enter the country in which you reside:

The information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”), Canada, Japan, Australia or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

I am currently physically present in:

The information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”), Canada, Japan, Australia or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

Access to this information is limited to persons resident and physically present in Sweden and to authorized persons who are resident and physically present in other jurisdictions outside the United States, Canada, Japan or Australia.